Steven R. Schow
2012
In 2012, Steven R. Schow earned a total compensation of $204.7K as Vice President, Research at MabVax Therapeutics Holdings, a 47% decrease compared to previous year.
Compensation breakdown
| Salary | $204,667 |
|---|---|
| Total | $204,667 |
Schow received $204.7K in salary, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Steven R. Schow's compensation ranked 10,833rd out of 11,487 executives tracked by ExecPay. In other words, Schow earned more than 5.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,833 out of 11,487 | 6th |
Division Manufacturing | 4,038 out of 4,253 | 5th |
Major group Chemicals And Allied Products | 1,129 out of 1,198 | 6th |
Industry group Drugs | 864 out of 920 | 6th |
Industry Pharmaceutical Preparations | 659 out of 700 | 6th |
Source: SEC filing on April 5, 2013.
Schow's colleagues
We found four more compensation records of executives who worked with Steven R. Schow at MabVax Therapeutics Holdings in 2012.
2012
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2012
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2012
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
2012
Marc Steuer
MabVax Therapeutics Holdings